Cargando…

Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis

Using bone‐avid radiotracers, cardiac transthyretin (TTR) amyloidosis can be diagnosed by scintigraphy, thus obviating endomyocardial biopsy. Radiotracer accumulation, however, may also be due to other causes. A 68‐year‐old male with acute myocardial infarction underwent recanalization of the left a...

Descripción completa

Detalles Bibliográficos
Autores principales: Makivic, Nina, Stöllberger, Claudia, Nakuz, Thomas, Schneider, Birke, Schmid, Christine, Hasun, Matthias, Weidinger, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373919/
https://www.ncbi.nlm.nih.gov/pubmed/32515557
http://dx.doi.org/10.1002/ehf2.12771
_version_ 1783561588724203520
author Makivic, Nina
Stöllberger, Claudia
Nakuz, Thomas
Schneider, Birke
Schmid, Christine
Hasun, Matthias
Weidinger, Franz
author_facet Makivic, Nina
Stöllberger, Claudia
Nakuz, Thomas
Schneider, Birke
Schmid, Christine
Hasun, Matthias
Weidinger, Franz
author_sort Makivic, Nina
collection PubMed
description Using bone‐avid radiotracers, cardiac transthyretin (TTR) amyloidosis can be diagnosed by scintigraphy, thus obviating endomyocardial biopsy. Radiotracer accumulation, however, may also be due to other causes. A 68‐year‐old male with acute myocardial infarction underwent recanalization of the left anterior descending coronary artery (LAD). Postinterventionally, transthoracic echocardiography showed hypokinesia of the septum and anterior wall and a thickened myocardium with granular sparkling appearance. Cardiac amyloidosis was suspected. A 99mTc‐3,3‐diphosphono‐1,2‐propanodicarboxylic acid whole‐body scan 4 days after LAD recanalization showed Perugini 2 myocardial tracer uptake. Monoclonal gammopathy was excluded, and cardiac TTR amyloidosis was diagnosed. Three months later, 99m‐Tc‐hydroxydiphosphate scan showed no myocardial tracer uptake. Cardiac magnetic resonance imaging revealed late gadolinium enhancement within the LAD supply area. No mutation of the TTR gene was found. Suspicion of amyloidosis should consider not only echocardiography but also history and clinical findings. Myocardial oedema due to reperfusion should be acknowledged as a differential diagnosis for cardiac uptake of bone‐avid radiotracers.
format Online
Article
Text
id pubmed-7373919
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73739192020-07-22 Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis Makivic, Nina Stöllberger, Claudia Nakuz, Thomas Schneider, Birke Schmid, Christine Hasun, Matthias Weidinger, Franz ESC Heart Fail Case Report Using bone‐avid radiotracers, cardiac transthyretin (TTR) amyloidosis can be diagnosed by scintigraphy, thus obviating endomyocardial biopsy. Radiotracer accumulation, however, may also be due to other causes. A 68‐year‐old male with acute myocardial infarction underwent recanalization of the left anterior descending coronary artery (LAD). Postinterventionally, transthoracic echocardiography showed hypokinesia of the septum and anterior wall and a thickened myocardium with granular sparkling appearance. Cardiac amyloidosis was suspected. A 99mTc‐3,3‐diphosphono‐1,2‐propanodicarboxylic acid whole‐body scan 4 days after LAD recanalization showed Perugini 2 myocardial tracer uptake. Monoclonal gammopathy was excluded, and cardiac TTR amyloidosis was diagnosed. Three months later, 99m‐Tc‐hydroxydiphosphate scan showed no myocardial tracer uptake. Cardiac magnetic resonance imaging revealed late gadolinium enhancement within the LAD supply area. No mutation of the TTR gene was found. Suspicion of amyloidosis should consider not only echocardiography but also history and clinical findings. Myocardial oedema due to reperfusion should be acknowledged as a differential diagnosis for cardiac uptake of bone‐avid radiotracers. John Wiley and Sons Inc. 2020-06-09 /pmc/articles/PMC7373919/ /pubmed/32515557 http://dx.doi.org/10.1002/ehf2.12771 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Makivic, Nina
Stöllberger, Claudia
Nakuz, Thomas
Schneider, Birke
Schmid, Christine
Hasun, Matthias
Weidinger, Franz
Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis
title Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis
title_full Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis
title_fullStr Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis
title_full_unstemmed Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis
title_short Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis
title_sort reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373919/
https://www.ncbi.nlm.nih.gov/pubmed/32515557
http://dx.doi.org/10.1002/ehf2.12771
work_keys_str_mv AT makivicnina reversiblemyocardialoedemaduetoacutemyocardialinfarctionasdifferentialdiagnosisofcardiactransthyretinamyloidosis
AT stollbergerclaudia reversiblemyocardialoedemaduetoacutemyocardialinfarctionasdifferentialdiagnosisofcardiactransthyretinamyloidosis
AT nakuzthomas reversiblemyocardialoedemaduetoacutemyocardialinfarctionasdifferentialdiagnosisofcardiactransthyretinamyloidosis
AT schneiderbirke reversiblemyocardialoedemaduetoacutemyocardialinfarctionasdifferentialdiagnosisofcardiactransthyretinamyloidosis
AT schmidchristine reversiblemyocardialoedemaduetoacutemyocardialinfarctionasdifferentialdiagnosisofcardiactransthyretinamyloidosis
AT hasunmatthias reversiblemyocardialoedemaduetoacutemyocardialinfarctionasdifferentialdiagnosisofcardiactransthyretinamyloidosis
AT weidingerfranz reversiblemyocardialoedemaduetoacutemyocardialinfarctionasdifferentialdiagnosisofcardiactransthyretinamyloidosis